Breast Cancer - Moose and Doc

A breast cancer explanations website

 

By Dr. Halls

References

 

  • Bijker N, van Tienhoven G. (2010) Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist’s perspective. J Natl Cancer Inst Monogr. (2010) 41:178-80. https://www.ncbi.nlm.nih.gov/pubmed/20956825
  • Calvocoressi L, Stowe MH, Carter D, Claus EB. (2012) Postmenopausal hormone therapy and ductal carcinoma in situ: A population-based case control study
    Cancer Epidemiol. 2012 Apr; 36(2): 161–168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613248/
  • Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, (et al). (2012) Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol. 2016 Jan;17(1):109-14. https://www.ncbi.nlm.nih.gov/pubmed/26655422
  • Evans WP, 3rd, Starr AL, Bennos ES. (1997) Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology. 1997 Aug;204(2):489-91. https://www.ncbi.nlm.nih.gov/pubmed/9240541
  • Feig SA, Shaber GS, Patchefsky A, (et al). (1977) Analysis of clinically occult and mammographically occult breast tumors. AJR Am J Roentgenol (Mar. 1977) 128(3):403-8. https://www.ncbi.nlm.nih.gov/pubmed/190908
  • Feig SA. (1995) Estimation of currently attainable benefit from mammogrpahic screening of women aged 40-49 years. Cancer(1995) 75:2412-2419. https://www.ncbi.nlm.nih.gov/pubmed/7736383
  • Feig, SA. (2000) Ductal Carcinoma in Situ; Implications for screening mammograpy. Radiologic Clinics of North America (July 2000)
    Volume 38 ,Number 4. https://www.ncbi.nlm.nih.gov/pubmed/10943269
  • Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA. (2006) Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. J Exp Clin Cancer Res. 2006 Jun;25(2):223-7. https://www.ncbi.nlm.nih.gov/pubmed/16918134
  • Kong I, Narod SA, Taylor C, Paszat L, MD, Saskin R, Moses N, Thiruchelvam D, (et al). (2014) Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis Curr Oncol. 2014 Feb; 21(1): e96–e104 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921054/
  • Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, (et al). (2010) Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010 May 5; 102(9): 627–637. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864293/
  • Leonard, GD, Swain SM. (2004) Ductal Carcinoma in Situ, Complexities and Challenges. J Natl Cancer Institute,(2004); 96(12):906-20 https://www.ncbi.nlm.nih.gov/pubmed/15199110
  • Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR. (et al). (2004) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ Journal of Clinical Oncology 2016 34:33, 4040-4046 http://ascopubs.org/doi/full/10.1200/JCO.2016.68.3573
  • Narod SA, Iqbal J, Giannakeas V, (et al). (2015) Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ JAMA Oncol. 2015 Oct;1(7):888-96. https://www.ncbi.nlm.nih.gov/pubmed/26291673
  • Perez AA, Balabram D, Almeida Salles M, Helenice Gobbi H.corresponding (2015) Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients Diagn Pathol. 2014; 9: 227. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260240/
  • Pinder SE, Duggan C, Ellis IO, Cuzick J, Forres JF, Bishop H, Fentiman IS, George WD (2010) Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma In Situ (DCIS) Working Party. .A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer. 2010 Jun 29; 103(1): 94–100.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905282/
  • Pisano ED. (2010) Mode of detection and secular time for ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):142-4. https://www.ncbi.nlm.nih.gov/pubmed/20956819
  • Silverstein MJ (editor), Recht A, Lagios MD. (2002) Ductal Carcinoma in Situ of the Breast Williams & Wilkins, 2002.
  • Tabar L. (2003) Teaching Course in Diagnostic Breast Imaging, Diagnosis and In-Depth Differential Diagnosis of Breast Diseases p. C-26, G-24, Montreal April 2003.
  • Tabar L, Dean PB, Kaufman CS, Duffy SW, Hsiu-Hsi Chen. (2000) A new era in the diagnosis of breast cancer. Surg Oncol Clin N Am. 2000 Apr;9(2):233-77. (Statistics from the Two-County Trial, Sweden published in International Journal of Cancer 1988, p. 413-419, 1996). https://www.ncbi.nlm.nih.gov/pubmed/10757844
  • Tabar L, Duffy S, Vitak B, et al. (1999) The natural history of breast cancer: What have we learned from screening? Cancer (1999)86:449-462 https://www.ncbi.nlm.nih.gov/pubmed/10430253
  • Tjalma WAA (2016) Is anti-hormonal treatment in DCIS of the breast a need? Facts Views Vis Obgyn. 2016 Sep; 8(3): 179–181. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172575/
  • Van Cleef A, Altintas S, Huizing M, Papadimitriou K, Dam V, Tjalma W. (2014) Current view on ductal carcinoma in situ and importance of the margin thresholds: A review Facts Views Vis Obgyn. 2014; 6(4): 210–218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286860/
  • Vicini FA, Recht A. (2002)
    Age at Diagnosis and Outcome for Women With Ductal Carcinoma-In-Situ of the Breast: A Critical Review of the Literature     Journal of Clinical Oncology 2002 20:11, 2736-2744 http://ascopubs.org/action/showCitFormats?doi=10.1200/JCO.2002.07.137
  • Virnig BA, Shamliyan T, Tuttle TM, Kane RL, Wilt TJ. (2010)Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Prepared by Minnesota Evidence-based Practice center, Minneapolis, Minnesota. 2010. https://www.ncbi.nlm.nih.gov/books/NBK32576/
  • Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N. (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. (2011);103:478-488. https://www.ncbi.nlm.nih.gov/pubmed/21398619
  • Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S. (2008) Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.J Med Screen.(2008);15(2):83-90. http://journals.sagepub.com/doi/pdf/10.1258/jms.2008.007071